The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.25
Bid: 8.50
Ask: 10.00
Change: -0.50 (-5.13%)
Spread: 1.50 (17.647%)
Open: 9.25
High: 9.50
Low: 9.25
Prev. Close: 9.75
NBB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

17 Oct 2017 11:18

RNS Number : 8253T
Norman Broadbent PLC
17 October 2017
 

Norman Broadbent plc

("Norman Broadbent" or the "Company")

Result of General Meeting

General Meeting

Norman Broadbent (AIM: NBB), a leading provider of Talent Acquisition & Advisory Services, comprising Board & Executive Search, Interim Management, Research & Insight, Leadership Consulting & Assessment, and executive level Recruitment Solutions, announces that all resolutions proposed at the Company's General Meeting, held today, were duly approved by shareholders.

As a result, shareholders have granted the Company's directors the authority to allot and issue 12,252,250 new ordinary shares of 1 pence each (the "Placing Shares") to raise a total of approximately £1.23m (the "Placing") (before expenses), as announced on 29 September 2017.

Significant Shareholders

Certain of the Company's substantial shareholders and directors have participated in the Placing on the same terms as other investors. The level of such participation, as well as each substantial shareholder and director's interests in the Company's issued share capital before and following completion of the Placing are set out below:

Existing substantial shareholder

Number of Ordinary Shares held before the Placing

Percentage of current issued Ordinary Share capital

Number of new Ordinary Shares subscribed for

Number of new Ordinary Shares held on Admission

Percentage of Enlarged Issued Share Capital

Downing LLP

10,528,003

25.29%

3,319,500

13,847,503

25.70%

Ennismore Fund Management Limited

7,453,992

17.90%

2,192,750

9,646,742

17.90%

Moulton Goodies Limited

6,066,739

14.57%

2,000,000

8,066,739

14.97%

Pierce Augustan Casey

5,775,005

13.87%

500,000

6,275,005

11.65%

 

Director

Number of Ordinary Shares held before the Placing

Percentage of current issued Ordinary Share capital

Number of Ordinary Shares held on Admission

Percentage of Enlarged Issued Share Capital

Mike Brennan

666,315

1.60%

916,315

1.70%

Frank Carter

157,894

0.38%

207,894

0.39%

Brian Stephens

117,955

0.28%

167,955

0.31%

 

Applications for Admission

Application will be made for the Placing Shares to be admitted to trading on AIM with admission expected to become effective on 18 October 2017.

Following Admission the Company will have 53,885,570 ordinary shares in issue. For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs"), the issued ordinary share capital of the Company following this allotment consists of 53,885,570 ordinary shares with voting rights attached (one vote per share). There are no shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the DTRs.

For further information, please contact:

Norman Broadbent plc

Mike Brennan / Will Gerrand

 

020 7484 0000

 WH Ireland Limited

Adrian Hadden / Jessica Cave / Alex Bond

  

0207 220 1666

For further information visit www.normanbroadbent.com

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROMBDLFFDBFFFBF
Date   Source Headline
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings
20th Mar 20241:36 pmRNSNotice of Results & Investor Presentation
18th Mar 20244:33 pmRNSNotification of major holdings
18th Mar 20244:04 pmRNSNotification of major holdings
12th Mar 20243:33 pmRNSAIM Rule 17 Schedule Two (g) Update
22nd Jan 20245:32 pmRNSNotification of Major Holdings
16th Jan 20247:00 amRNSTrading Update
21st Nov 202310:06 amRNSNotification of Major Holdings
20th Nov 202310:45 amRNSDirector/PDMR shareholding
15th Nov 20239:54 amRNSNotification of Major Holdings
15th Nov 20239:43 amRNSNotification of Major Holdings
10th Nov 20237:00 amRNSDirector/PCA Dealing
9th Nov 20232:25 pmRNSDirector/PDMR Shareholding
2nd Nov 20238:43 amRNSConversion Of Outstanding Convertible Loan Notes
12th Oct 20237:00 amRNSQ3 2023 Trading Update
10th Oct 202311:03 amRNSNotification of Major Holdings
9th Oct 20237:00 amRNSSurrender and Granting of Options
28th Jul 20237:00 amRNSGrant of Options
24th Jul 20237:00 amRNSInterim Results
11th Jul 20237:00 amRNSH1 2023 Trading Update
30th Jun 20237:00 amRNSSAYE Option Plan & Director Holding
29th Jun 20234:28 pmRNSResult of AGM
5th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 20237:00 amRNSDirectorate changes
31st May 20237:00 amRNSFinal Results
22nd May 20237:00 amRNSQ1 2023 Trading Update
19th May 202312:55 pmRNSPartial Repayment of Convertible Loan Note
24th Jan 20237:00 amRNSTrading Update
10th Jan 20237:00 amRNSDirectorate Change
17th Nov 20224:42 pmRNSTR-1: Notification of major holdings
14th Nov 20227:00 amRNSIssue of Equity
1st Nov 20227:00 amRNSUpdate and Change of Board role
10th Oct 20225:30 pmRNSTR-1: Notification of major holdings
31st Aug 20227:00 amRNSDirector Share Purchase
23rd Aug 20227:00 amRNSDirectorate Change
16th Aug 20227:00 amRNSInterim Results
29th Jul 20227:00 amRNSChange of Adviser
20th Jul 20224:08 pmRNSDirector/PDMR Dealing
11th Jul 20227:00 amRNSTrading Update
29th Jun 20223:15 pmRNSDirector/PDMR Shareholding
23rd Jun 202212:14 pmRNSResult of AGM
7th Jun 20228:59 amRNSHolding(s) in Company
25th May 20227:00 amRNSFinal 2021 Results and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.